A: Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can prompt your body to make more insulin, which lowers your blood sugar
References: Intermittent pneumatic compression therapy: a systematic review Effects of Intermittent Pneumatic Compression on Delayed Onset Muscle Soreness (DOMS) in Long Distance Runners A systematic review of pneumatic compression for treatment of chronic venous insufficiency and venous ulcers Effects of lower-limb intermittent pneumatic compression on sports recovery: A systematic review and meta-analysis Effects of daily use of intermittent pneumatic compression in competitive handball players: A randomized controlled trial Infrared therapy for chronic low back pain: a randomized, controlled trial Effects of local vibration therapy on various performance parameters: a narrative literature review Long-term results of vibratory stimulation as a pain relieving measure for chronic pain Assessment of Countermovement Jump: What Should We Report

[27] Additionally, anyone with Lebers hereditary optic neuropathy (a rare inherited eye disease) must avoid cyanocobalamin injections, since B can precipitate rapid worsening of that condition
Foundayo (orforglipron) is a versatile oral GLP-1 type, taken any time without food or water restrictions, while Zepbound (tirzepatide) combines GLP-1 and GIP agonists for enhanced results
They should arrange appropriate monitoring, including regular HbA1c checks to assess diabetes control and periodic review of your treatment goals